Itai Levi

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Moderate to severe thrombocytopenia during pregnancy

Michal Parnas, Eyal Sheiner, Ilana Shoham‐Vardi et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2006 · 155 citations

Medicine, Hematology, Obstetrics +8

Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I

Hannah Tamary, Hanna Shalev, Galit Perez‐Avraham et al. · Blood · 2008 · 139 citations · Full text

Medicine, Genetics, Hematology +5

A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

Avichai Shimoni, Irit Avivi, Jacob M. Rowe et al. · Cancer · 2012 · 108 citations

Medicine, Oncology, Chemotherapy +14

The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells

Irene Bobilev, Victoria Novik, Itai Levi et al. · Cancer Biology & Therapy · 2011 · 66 citations · Full text

Life Sciences, Oncology, Pharmacology +17